Getting diagnosed is one thing. But what comes after diagnosis - knowing which tests actually apply to your type, what to repeat and when, and what to watch for long-term - is where most women are left to figure things out on their own.
This part is your cheat sheet. We’re bringing together everything from the previous three parts: your phenotype, the tests that matter for it, and what good ongoing PMOS care actually looks like now that the name finally reflects the whole condition.
Which tests matter most for your type
Not all tests are equally urgent for all phenotypes. Your phenotype shapes the priority of your workup - and understanding that helps you ask better questions and notice gaps in your care.
Sources: 2023 International Evidence-Based PCOS Guidelines; RRM Academy; The Lancet (2026)
Types A and B: The metabolic workup - especially the OGTT - isn’t optional. It should be the first thing on your list, even if your weight is in the “normal” range. Insulin resistance in PMOS does not wait for obesity to arrive.
Ongoing care: what to monitor and when
PMOS is a lifelong condition. That doesn’t mean it’s a life sentence - it means it responds to ongoing attention, the way you’d maintain a car or a garden. The monitoring isn’t about waiting for something to go wrong. It’s about catching things early, when they’re easy to address.
Sources: RCOG Green-top Guideline No. 33 · Frontiers - Lipid Profile & PCOS Risk
The care shift the new name is meant to trigger
“PMOS is not just a fertility condition with some inconvenient side effects. The new name exists so that doctors finally treat it like the whole-body condition it is.”
Here is what good PMOS care looks like now, post-rename:
Before: You were diagnosed and sent home with a pamphlet about losing weight and maybe a prescription for the pill. The metabolic tests weren’t ordered. Your cardiovascular risk wasn’t assessed. Nobody mentioned your thyroid, your insulin, or the fact that anxiety and depression are nearly twice as common in women with PMOS.
Now: A PMOS diagnosis should trigger a full hormonal and metabolic workup from the start. It should involve a care team that includes more than one specialty. And it should come with a clear monitoring plan - not a one-time assessment.
What to ask your next appointment: “Which phenotype do I have?” “Has my insulin resistance been assessed with an OGTT, not just fasting glucose?” “Has my cardiovascular risk been reviewed?” These are legitimate, important questions - and if they’re met with a blank look, a second opinion is worth pursuing.
When a second opinion changes things
Here’s the honest truth: 86% of women surveyed said the old name contributed to their care being dismissed or misframed. That’s not a small number - it’s the majority. Average time to diagnosis under the old system was two or more years. The name change is meant to fix some of that. But cultural change in medicine takes time, and the right specialist knowledge still isn’t evenly distributed.
A second opinion from a specialist who understands PMOS properly can mean the difference between “your labs are fine” and a care plan that actually addresses what’s happening in your body.